HSP90AB1 and glioblastoma: HSP90 inhibitors such as Radicicol, BIIB021, NVP-AUY922, and VER-50589, which lack a quinone moiety, did not demonstrate cross-resistance in 17-AAG-resistant GBM cell lines [137].